NPR

As CBD Oils Become More Popular, The FDA Considers Whether To Set New Rules

The marijuana and hemp extract has been touted as a way to ease anxiety and inflammation, despite limited science. Now, the FDA is holding its first public hearing on cannabidiol.
Cannabidiol, or CBD, is a compound that can be extracted from marijuana or from hemp. It doesn't get people high because it doesn't contain THC, the psychoactive component of the cannabis plant.

The Food and Drug Administration is holding its first public hearing on CBD, the cannabis extract that has quickly grown into a billion-dollar industry. Today's hearing will help officials determine how to regulate CBD products.

The compound can be extracted from marijuana or from hemp. It's promoted as a way to ease anxiety and inflammation – and it doesn't get people high because it doesn't contain THC, the psychoactive component

You’re reading a preview, subscribe to read more.

More from NPR

NPR2 min readCrime & Violence
Guatemalan AG Raids Save The Children Office Over A Migrant Children Rights Complaint
Prosecutor Rafael Curruchiche said that the complaint filed by an unidentified foreigner had raised serious concerns because it involved allegations of abuse of children.
NPR3 min readAmerican Government
Trump's Immunity Arguments And The Experiences Of The Justices Who Might Support It
Five of the six conservatives spent much of their lives in the Beltway, working in the White House and Justice Department, seeing their administrations as targets of unfair harassment by Democrats.
NPR7 min read
As Bird Flu Spreads In Cows, Here Are 4 Big Questions Scientists Are Trying To Answer
Health officials say there's very little risk to humans from the bird flu outbreak among dairy cattle, but there's still much they don't know. Here are four questions scientists are trying to answer.

Related Books & Audiobooks